A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102
Clinical trial NCT03613662 · COMPLETED
Trial details
- NCT number
- NCT03613662
- Sponsor
- Semnur Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-13
- Primary completion
- 2019-03-15
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.